These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7076770)

  • 1. Simultaneous determination of dantrolene and its metabolite, 5-hydroxydantrolene, in human plasma by high-performance liquid chromatography.
    Katogi Y; Tamaki N; Adachi M; Terao J; Mitomi M
    J Chromatogr; 1982 Mar; 228():404-8. PubMed ID: 7076770
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous determination of dantrolene and its metabolites, 5-hydroxydantrolene and nitro-reduced acetylated dantrolene (F 490), in plasma and urine of man and dog by high-performance liquid chromatography.
    Wuis EW; Grutters AC; Vree TB; van der Kleyn E
    J Chromatogr; 1982 Sep; 231(2):401-9. PubMed ID: 7130316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of dantrolene sodium in human plasma using high-performance liquid chromatography.
    Hackett LP; Dusci LJ
    J Chromatogr; 1979 Nov; 179(1):222-4. PubMed ID: 536456
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of intravenously administered dantrolene and its 5-hydroxy metabolite in dogs.
    Wuis EW; Vree TB; Van Der Kleijn E
    Int J Clin Pharmacol Res; 1990; 10(4):203-10. PubMed ID: 2079379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous dantrolene in children.
    Lerman J; McLeod ME; Strong HA
    Anesthesiology; 1989 Apr; 70(4):625-9. PubMed ID: 2929999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum concentration and daily dose of dantrolene in cerebral palsy patients.
    Inotsume N; Higashi A; Matsukane I; Chikazawa S; Nakano M; Matsuda I
    Pediatr Pharmacol (New York); 1986; 5(4):253-9. PubMed ID: 3737270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of dantrolene and its reduced and oxidized metabolites in plasma by high-performance liquid chromatography.
    Lalande M; Mills P; Peterson RG
    J Chromatogr; 1988 Aug; 430(1):187-91. PubMed ID: 3215956
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of dantrolene in horses.
    DiMaio Knych HK; Arthur RM; Taylor A; Moeller BC; Stanley SD
    J Vet Pharmacol Ther; 2011 Jun; 34(3):238-46. PubMed ID: 21492188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-determination of ketoconazole in plasma or serum by high-performance liquid chromatography.
    Badcock NR
    J Chromatogr; 1984 Mar; 306():436-40. PubMed ID: 6325484
    [No Abstract]   [Full Text] [Related]  

  • 10. Liquid chromatography in pharmaceutical analysis VII: determination of dantrolene sodium in biological fluids.
    Saxena SJ; Honigberg IL; Stewart JT; Vallner JJ
    J Pharm Sci; 1977 May; 66(5):751-3. PubMed ID: 874769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological effects of intravenous dantrolene on canine heart.
    Roewer N; Kuck KH; Kochs E; Schulte am Esch J
    Eur J Anaesthesiol; 1987 Sep; 4(5):357-67. PubMed ID: 3428281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dantrolene sodium: urinary metabolites and hepatotoxicity.
    Arnold TH; Epps JM; Cook HR; Hamrick ME
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):381-98. PubMed ID: 6856946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.
    Jayyosi Z; Villoutreix J; Ziegler JM; Batt AM; De Maack F; Siest G; Thomas PE
    Drug Metab Dispos; 1993; 21(5):939-45. PubMed ID: 7902259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic method for the simultaneous determination of lidocaine and its N-dealkylated metabolites in plasma.
    Nation RL; Peng GW; Chiou WL
    J Chromatogr; 1979 Mar; 162(3):466-73. PubMed ID: 528615
    [No Abstract]   [Full Text] [Related]  

  • 15. High-performance liquid chromatographic assay for monitoring indapamide and its major metabolite in urine.
    Pietta P; Calatroni A; Rava A
    J Chromatogr; 1982 Mar; 228():377-81. PubMed ID: 7076765
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of a dantrolene metabolite, 5-(p-nitrophenyl)-2-furoic acid, in plasma and urine by high-performance liquid chromatography.
    Wuis EW; Janssen MG; Vree TB; van der Kleijn E
    J Chromatogr; 1990 Apr; 526(2):575-80. PubMed ID: 2361999
    [No Abstract]   [Full Text] [Related]  

  • 17. Voltammetric analysis of dantrolene and its active metabolite with indomethacin in rat plasma.
    Ragab MA; Korany MA; Galal SM; Ahmed AR
    Bioanalysis; 2019 Jan; 11(2):73-84. PubMed ID: 30539646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of pentazocine in plasma.
    Moeller N; Dietzel K; Nuernberg B; Geisslinger G; Brune K
    J Chromatogr; 1990 Aug; 530(1):200-5. PubMed ID: 2277113
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous determination of dipyrone metabolites in plasma by high-performance liquid chromatography.
    Katz EZ; Granit L; Drayer DE; Levy M
    J Chromatogr; 1984 Feb; 305(2):477-84. PubMed ID: 6707174
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of the antispasmodic agent ethaverine in human plasma by high-performance liquid chromatography.
    Brodie RR; Chasseaud LF; Walmsley LM; Soegtrop HH; Darragh A; O'Kelly DA
    J Chromatogr; 1980 Jun; 182(3-4):379-86. PubMed ID: 7391180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.